Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
16.20
-0.28 (-1.70%)
Nov 17, 2026, 3:00 PM CST
| Market Cap | 7.39B -43.5% |
| Revenue (ttm) | 1.38B -6.6% |
| Net Income | 112.54M +50.6% |
| EPS | 0.24 +44.8% |
| Shares Out | 455.90M |
| PE Ratio | 67.05 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,586,723 |
| Open | 16.38 |
| Previous Close | 16.48 |
| Day's Range | 16.11 - 16.54 |
| 52-Week Range | 16.12 - 32.99 |
| Beta | -0.01 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 30, 2026 |